bibliographic entry 6949527 [be/6949527]
https://w3id.org/oc/corpus/be/6949527

is a

• bibliographic reference

content

• Pratley RE, Reusch JEB, Fleck PR, Wilson CA, Mekki Q. Alogliptin Study 009 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Curr Med Res Opin 2009; 25:2361-71. doi:10.1185/03007990903156111. 19650752.

references

• https://w3id.org/oc/corpus/br/2310792